Abstract:Historically, there has been a scarcity of evidence-based topical therapy to hasten the healing of diabetic foot ulcers. But recently new evidence-based treatments have emerged from multicentre, randomised, controlled trials. This article highlights those trials, and describes the current pharmacological management of the diabetic foot ulcer and the advances that have been made in wound therapy to date. It provides an overview of topical and systemic pharmacotherapies in current use and those in development for future use in managing the diabetic foot. For each treatment, proposed mechanisms of action and evidence available to support their clinical use are presented. There is supporting randomised, controlled evidence for sucrose octasulfate in the treatment of neuro-ischaemic ulcers, and multi-layered patch of autologous leucocytes, platelets and fibrin in ulcers with or without ischaemia. There is also evidence for placentally derived products and for topical and systemic oxygen therapy in the healing of diabetic foot ulcers. Growth factors, bio-engineered tissues, stem cell therapy, gene therapy and peptide therapy also have some supporting evidence in the healing of diabetic foot ulcers. Nonsurgical debriding agents may be useful when the optimum approach of sharp debridement is not possible, and immunomodulators may be helpful for their antimicrobial effects, but robust data is still required to strengthen the case for general use. The review does not cover antimicrobials as their primary role are as anti-infectives and not in wound healing. The development of nanotechnology has created a means of prolonging the bioavailability of target molecules at the wound site, with the use of glass/hydrogel nanoparticles, polyethylene glycol and hyaluronic acid. Looking forward, novel therapies, including traction force-activated payloads, local delivery of short-interfering RNA and finally hydrogels incorporating bioactive agents or cells may provide possibilities for pharmacotherapy in the future.

Nanotechnology invigorated drug delivery and tissue engineering strategies for the management of diabetic foot ulcers: Therapeutic approaches and clinical applications

Moving beyond nanotechnology to uncover a glimmer of hope in diabetes medicine: Effective nanoparticle‐based therapeutic strategies for the management and treatment of diabetic foot ulcers

Narrative review on nanoparticles based on current evidence: therapeutic agents for diabetic foot infection

Physiological and Pathophysiological Aspects of Diabetic Foot Ulcer and its Treatment Strategies

Microenvironment‐Based Diabetic Foot Ulcer Nanomedicine

Nanoparticles for Delivering Micro and Macromolecules for the Management of Diabetic Wounds

Stem Cell-Based Tissue Engineering Approaches for Diabetic Foot Ulcer: a Review from Mechanism to Clinical Trial

Experimental treatments in clinical trials for diabetic foot ulcers: wound healers in the pipeline

Diabetic foot ulcer: Challenges and future

Recent advances in the adjunctive management of diabetic foot ulcer: Focus on noninvasive technologies

Advances in nucleic acid delivery strategies for diabetic wound therapy

Exploring Photobiomodulation Therapy and Regenerative Medicine for Diabetic Foot Ulcers: Pathogenesis and Multidisciplinary Treatment Approach

Recent trends in diabetic wound healing with nanofibrous scaffolds

Molecular immunological mechanisms of impaired wound healing in diabetic foot ulcers (DFU), current therapeutic strategies and future directions

Granular Porous Nanofibrous Microspheres Enhance Cellular Infiltration for Diabetic Wound Healing

Emerging Trends in Nano‐Functionalized Scaffolds for Chronic Wound Healing

Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing

On diabetic foot ulcer knowledge gaps, innovation, evaluation, prediction markers, and clinical needs

Leveraging smart technologies to improve the management of diabetic foot ulcers and extend ulcer‐free days in remission

Diabetic Foot Infection, Biofilm & New Management Strategy

Emerging Antimicrobial and Immunomodulatory Fiber-Based Scaffolding Systems for Treating Diabetic Foot Ulcers